Synergetic Enhancement of Fluorescence and Magnetic Resonance Signals Assisted by Albumin Cage

22 October 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Bimodal fluorescence and magnetic resonance imaging (FLI/MRI) is important for early diagnosis of malignant tumors. Yet, facile and opportune strategies to synergistically enhance fluorescence intensity and magnetic resonance (MR) contrast effect have been rarely reported. Here, a facile albumin cage (AC) strategy is provided to synergistically enhance the fluorescence intensity by aggregation-induced emission (AIE) and MR contrast with prolonged rotational correlation time (τR) of Gd(III) chelates and diffusion correlation time (τD) of surrounding water molecules. The amphiphilic bimodal FLI/MRI probe of NGd, could be facilely loaded into ACs to generate supramolecular structure of NGd-albumin cages (NGd-ACs), which show excellent biocompatibility and biosafety, and exhibit superior fluorescence quantum yield and r1 over NGd with 6- and 8-fold enhancement, respectively. Moreover, compared with clinical MRI contrast agent of Gd-DOTA, r1 of NGd-AC shows 17-fold enhancement. As a result, NGd-ACs successfully elicit high-performance bimodal FLI/MRI in vitro and brighter MR signals are observed in liver and tumor after intravenous injection of NGd-ACs with a dosage of 6 μmol Gd(III)/kg body weight. This strategy is generic and feasible, and successfully realizes a “1+1>2” effect for dual-modal FLI/MRI.

Keywords

albumin cage
fluorescence
magnetic resonance signal
aggregation-induced emission
synergetic enhancement

Supplementary materials

Title
Description
Actions
Title
Manuscript-20201021
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.